We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+11.5%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.38B
AUM Growth
-$101M
Cap. Flow
-$196M
Cap. Flow %
-8.23%
Top 10 Hldgs %
21.35%
Holding
276
New
33
Increased
38
Reduced
163
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 24.67%
2 Healthcare 22.79%
3 Industrials 22.78%
4 Financials 9.47%
5 Consumer Discretionary 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FA icon
51
First Advantage
FA
$3.83B
$18.6M 0.78%
1,158,833
-37,120
-3% -$598K
LNW
52
DELISTED
Light & Wonder
LNW
$18.5M 0.78%
176,434
-5,322
-3% -$508K
SYNA icon
53
Synaptics
SYNA
$4.46B
$17.8M 0.75%
202,283
+72,611
+56% +$6.58M
VKTX icon
54
Viking Therapeutics
VKTX
$4.31B
$17.3M 0.73%
327,046
+16,039
+5% +$1.05M
BBIO icon
55
BridgeBio Pharma
BBIO
$15.9B
$16.9M 0.71%
666,344
-32,739
-5% -$895K
VITL icon
56
Vital Farms
VITL
$581M
$16M 0.67%
+341,603
New +$11.8M
INDI icon
57
indie Semiconductor
INDI
$809M
$15.6M 0.66%
2,534,106
-237,917
-9% -$1.51M
LITE icon
58
Lumentum
LITE
$57B
$14.9M 0.63%
293,182
-4,621
-2% -$209K
TREE icon
59
LendingTree
TREE
$645M
$14.4M 0.6%
345,892
+2,247
+0.7% +$94.8K
IDCC icon
60
InterDigital
IDCC
$6.73B
$14M 0.59%
120,412
+120,318
+127,998% +$12.9M
WHD icon
61
Cactus
WHD
$3.78B
$13.7M 0.57%
258,826
-10,416
-4% -$530K
TVTX icon
62
Travere Therapeutics
TVTX
$5.27B
$13.5M 0.56%
1,637,146
-112,255
-6% -$756K
RHP icon
63
Ryman Hospitality Properties
RHP
$7.99B
$13.4M 0.56%
134,474
-4,538
-3% -$478K
XPRO icon
64
Expro Ltd
XPRO
$1.87B
$13.4M 0.56%
+585,578
New +$12.1M
SPXC icon
65
SPX Corp
SPXC
$10.6B
$13.3M 0.56%
+93,890
New +$12.4M
CCOI icon
66
Cogent Communications
CCOI
$549M
$13.2M 0.56%
234,602
-8,231
-3% -$491K
ACAD icon
67
Acadia Pharmaceuticals
ACAD
$4.38B
$13.1M 0.55%
808,831
-842,293
-51% -$13.6M
UTZ icon
68
Utz Brands
UTZ
$638M
$12.5M 0.53%
752,957
-43,836
-6% -$789K
WVE icon
69
Wave Life Sciences
WVE
$1.12B
$12.4M 0.52%
+2,493,230
New +$14.2M
TRNO icon
70
Terreno Realty
TRNO
$7.94B
$12.3M 0.52%
208,338
-9,035
-4% -$520K
FN icon
71
Fabrinet
FN
$17.1B
$12.2M 0.51%
+49,808
New +$10.6M
AKRO
72
DELISTED
Akero Therapeutics
AKRO
$12.1M 0.51%
515,252
-23,621
-4% -$505K
ZUO
73
DELISTED
Zuora, Inc.
ZUO
$12.1M 0.51%
1,214,758
-80,620
-6% -$775K
SLNO
74
DELISTED
Soleno Therapeutics
SLNO
$12M 0.5%
293,328
-7,048
-2% -$299K
HLI icon
75
Houlihan Lokey
HLI
$9.67B
$11.8M 0.5%
87,583
-77,484
-47% -$10.1M

Similar funds

Emerald Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, Emerald Advisers held 276 positions worth $2.38B, down 4.1% from $2.49B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Emerald Advisers withdrew a net $196M in Q2 2024, closing 29 positions and reducing 163 holdings. Its most notable exit was Treace Medical Concepts, an estimated $20.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Emerald Advisers opened a new position in Modine Manufacturing worth $26.1M.

  • Emerald Advisers's largest Q2 2024 buy was Modine Manufacturing: 260,150 shares worth $26.1M.
  • Emerald Advisers added most to InterDigital in Q2 2024, an estimated $12.9M increase.
  • Emerald Advisers's biggest Q2 2024 reduction was Super Micro Computer, cutting an estimated $75.9M.
  • Emerald Advisers fully exited Treace Medical Concepts in Q2 2024, selling an estimated $20.4M.
  • Emerald Advisers's ten largest holdings make up 21% of its $2.38B portfolio in Q2 2024.
  • Emerald Advisers opened 33 new positions and closed 29 in Q2 2024.
  • Emerald Advisers's portfolio value fell 4.1% quarter-over-quarter to $2.38B.

Based on Emerald Advisers's 13F filing for Q2 2024, filed 6 Aug 2024.